Generex Biotechnology Corporation (OTCMKTS:GNBT) announced that Dr. Eric von Hofe, PhD, President of the Company’s wholly-owned subsidiary. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.04 in last session, and closed at $0.0375, while the day range of stock is $0.04 – $0.04. The stock showed a negative weekly performance of -6.25%.
Delcath Systems, Inc. (NASDAQ:DCTH) announced that it will host a conference call and webcast on Wednesday, March 12, 2014 at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year of 2013 ended December 31, 2013, and provide an update on recent corporate progress. Delcath Systems, Inc. (NASDAQ:DCTH) stock opened at $0.32, in last session and closed at $0.315, by losing -1.25%. The 52 week range of the stock is $0.22 – $2.19. Company’s market capitalization is $39.79 million.
Aegis Capital maintains Valeant Pharmaceuticals Int’l (NYSE:VRX) at Buy with a 12-month price target of $160 following the announcement Monday that it will acquire PreCision Dermatology. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock decreased -0.46% and finished the last session at $145.06. The EPS of the stock remained -3.26. Company’s market capitalization is $48.33 billion.
Alkermes plc (NASDAQ:ALKS) announced that its corporate presentation will be webcast live at the Cowen and Company 34th Annual Health Care Conference on Monday, March 3, 2014, at 2:50 p.m. EST (7:50 p.m. GMT) from The Boston Marriott Copley Place in Boston. Alkermes Plc (NASDAQ:ALKS) stock opened the session at $53.64, and closed the session at $53.82. The 52 week range of the stock remained $19.77 – $54.25 and the day range was $53.13 – $54.25.